Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children, 6737-6738 [E7-2362]

Download as PDF Federal Register / Vol. 72, No. 29 / Tuesday, February 13, 2007 / Notices 6737 ANNUAL BURDEN ESTIMATES Number of responses per respondent Average burden hours per response 51 35 16 30 1 1 1 1 0.333333 1.0 0.3 1.0 17.0 35.0 4.8 30.0 Administrator .................................................................................................... Supervisor ........................................................................................................ Line Staff .......................................................................................................... Partner Organization ........................................................................................ Observation ...................................................................................................... 6 12 18 12 12 1 1 1 1 1 1.5 1.0 1.0 1.0 ........................ 9.0 12.0 18.0 12.0 ........................ Estimated Total Annual Burden Hours: .................................................... ........................ ........................ ........................ 137.8 Number of respondents Instrument Total burden hours Survey of States Stage Stage Stage Stage 1: 2: 3: 4: State Survey ..................................................................................... Interview State TANF Director with Diversion Program ................... Interview State TANF Director without Diversion Program .............. Interview Local TANF Administrator ................................................. Site Visit Protocols Additional Information: Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L’Enfant Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. E-mail address: infocollection@acf.hhs.gov. All requests should be identified by the title of the information collection. OMB Comment: OMB is required to make a decision concerning the collection of information between 30 and 60 days after the publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Fax: 202–395–6974, Attn: Desk Officer for the Administration for Children and Families. Dated: February 7, 2007. Robert Sargis, Reports Clearance Officer. [FR Doc. 07–632 Filed 2–12–07; 8:45 am] BILLING CODE 4184–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES jlentini on PROD1PC65 with NOTICES Health Resources and Services Administration Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children Health Resources and Services Administration (HRSA), HHS. AGENCY: VerDate Aug<31>2005 16:55 Feb 12, 2007 Jkt 211001 Notice of request for nominations. ACTION: SUMMARY: The Health Resources and Services Administration (HRSA) is requesting nominations to fill eight (8) vacancies on the Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children. Authority: Section 1111 of the PHS Act, 42 U.S.C. 300b–10. The Committee is governed by the provisions of Public Law 92–463, as amended (5 U.S.C. App. 2), and 41 CFR Part 102–3, which sets forth standards for the formation and use of advisory committees. The agency must receive nominations on or before March 15, 2007. DATES: All nominations are to be submitted to Michele A. Lloyd-Puryear, M.D., Ph.D., Designated Federal Official and Executive Secretary, Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children, and Chief, Genetic Services Branch, Maternal and Child Health Bureau, Health Resources and Services Administration, Room 18A–19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. Nominations will not be accepted by email or facsimilie. FOR FURTHER INFORMATION CONTACT: Ms. Jill F. Shuger, Genetic Services Branch, Maternal and Child Health Bureau, HRSA, at jshuger@hrsa.gov or (301) 443–1080. A copy of the Committee Charter and list of the current membership can be obtained by contacting Ms. Shuger or by accessing the Advisory Committee Web site at http://mchb.hrsa.gov/programs/ genetics/committee. SUPPLEMENTARY INFORMATION: Title XXVI of the Children’s Health Act of 2000, ‘‘Screening for Heritable Disorders,’’ ADDRESSES: PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 established a program to improve the ability of States to provide newborn and child screening for heritable disorders. Title XXVI enacts three sections of the Public Health Service (PHS) Act: Sections 1109, 1110, and 1111. The Secretary of Health and Human Services (HHS) is directed under section 1111 of the PHS Act to establish an Advisory Committee on Heritable Disorders in Newborns and Children (Committee). HHS has expanded the Committee to include genetic diseases and has renamed the Committee accordingly. The Committee is established to advise and guide the Secretary regarding the most appropriate application of universal newborn screening tests, technologies, policies, guidelines and programs for effectively reducing morbidity and mortality in newborns and children having or at risk for heritable disorders. In addition, the Committee provides advice and recommendations to the Secretary concerning the grants and projects authorized under section 1109 and technical information to develop policies and priorities for this Program that will enhance the ability of the State and local health agencies to provide for newborn and child screening, counseling and health care services for newborns and children having or at risk for heritable disorders. Specifically, HRSA is requesting nominations for eight voting members to serve on the Committee. Members shall be selected from medical, technical, public health or scientific professionals with special expertise in the field of heritable disorders or in providing screening, counseling, testing or specialty services for newborns and children at risk for heritable disorders and from members of the public having E:\FR\FM\13FEN1.SGM 13FEN1 jlentini on PROD1PC65 with NOTICES 6738 Federal Register / Vol. 72, No. 29 / Tuesday, February 13, 2007 / Notices special expertise about or concern with heritable disorders. The individuals selected for appointment to the Committee can be invited to serve for overlapping terms of up to 4 years. However, any member appointed to fill a vacancy of an unexpired term shall be appointed for the remainder of such term. Members may serve after the expiration of their term until their successors have taken office. Terms of more than 2 years are contingent upon the renewal of the Committee by appropriate action prior to its expiration. Members who are not Federal employees will receive a stipend for each day they are engaged in the performance of their duties as members of the Committee. Members shall receive per diem and travel expenses as authorized by Section 5 U.S.C. 5703 for persons employed intermittently in Government service. Members who are officers or employees of the United States Government shall not receive compensation for service on the Committee. Nominees will be invited to serve beginning from September 30, 2007. To allow the Secretary to choose from a highly qualified list of potential candidates, more than one nomination is requested per open position. Nominations should be typewritten. The following information should be included in the package of material submitted for each individual being nominated for consideration: (1) A letter of nomination that clearly states the name and affiliation of the nominee, the basis for the nomination (i.e., specific attributes which qualify the nominee for service in this capacity), and a statement that the nominee is willing to serve as a member of the Committee and appears to have no conflict of interest that would preclude the Committee membership—potential candidates will be asked to provide detailed information concerning consultancies, research grants, or contracts to permit evaluation of possible sources of conflicts of interest; (2) the nominator’s name, address, and daytime telephone number, and the home/or work address, telephone number, and e-mail address of the individual being nominated; and (3) a current copy of the nominee’s curriculum vitae. Please submit nominations no later than March 15, 2007. To the extent practicable, members of the Committee should have expertise in dealing with heritable disorders and genetic diseases that affect the racial and ethnic and geographical diversity of newborns served by the State newborn screening programs. The Department of Health and Human Services will ensure VerDate Aug<31>2005 16:55 Feb 12, 2007 Jkt 211001 that the membership of the Committee reflects an equitable geographical and gender distribution, provided that the effectiveness of the Committee would not be impaired. Appointments shall be made without discrimination on the basis of age, ethnicity, gender, sexual orientation, and cultural, religious, or socioeconomic status. Dated: February 6, 2007. Elizabeth M. Duke, Administrator. [FR Doc. E7–2362 Filed 2–12–07; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Poison Control Centers Stabilization and Enhancement Program Health Resources and Services Administration, HHS. ACTION: Notice; request for public comment. AGENCY: SUMMARY: The Health Resources and Services Administration (HRSA) is seeking comments from the public on its plan to institute a permanent deviation from a policy in the Department of Health and Human Services (HHS), Grants Policy Directive (GPD) 3.01 governing indirect cost recovery for one of its grant programs. The GPD states ‘‘HHS considers activities conducted by grantees that result in indirect charges a necessary and appropriate part of HHS grants, and HHS awarding offices must reimburse their share of these costs.’’ Although HRSA typically reimburses grantees for their full share of administrative overhead represented in approved indirect cost rates (which can be up to 50 percent), the agency believes, in the case of its Poison Control Program, that full recovery of overhead expenditures would be detrimental to the poison control centers (PCCs) funded under the program because of the financial instability of PCCs. The purpose of the HRSA Poison Control Centers Stabilization and Enhancement Grant Program is to assist PCCs in achieving financial stability, preventing poisonings and providing treatment recommendations for poisonings. Limiting indirect costs is necessary because many PCCs are located within institutions such as universities and hospitals that have established indirect cost rates in the range of 30 to 50 percent. It is in the best interest of PCCs to limit the indirect cost recovery to 10 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 percent, leaving 90 percent of the grant funds to achieve the objectives of the grant program. This limitation would be applicable to all awardees of the Poison Control Center Stabilization and Enhancement Grant Programs. DATES: If you wish to comment on any portion of this notice, HRSA must receive comments by March 15, 2007. ADDRESSES: You may submit comments by any of the following methods: • E-mail: lroche@hrsa.gov. Include ‘‘Poison Control Stabilization and Enhancement Program’’ in the subject line of the message. • Mail: Lori Roche, Division of Healthcare Preparedness, Healthcare Systems Bureau, Health Resources and Services Administration (HRSA), 5600 Fishers Lane, Room 13–103, Rockville, MD 20857. • Hand Delivery/Courier: Lori Roche, Division of Healthcare Preparedness, Healthcare Systems Bureau, Health Resources and Services Administration (HRSA), 5600 Fishers Lane, Room 13– 103, Rockville, MD 20857. Docket: For access to the docket to read background documents or comments received, go to the Division of Healthcare Preparedness, Healthcare Systems Bureau, Health Resources and Services Administration (HRSA), 5600 Fishers Lane, Room 13–103, Rockville, Maryland, 20857, weekdays between the hours of 8:30 a.m. and 5 p.m. To schedule an appointment to view public comments, phone (301) 443–0652. FOR FURTHER INFORMATION CONTACT: Lori Roche, at the above address, telephone number 301–443–0652. SUPPLEMENTARY INFORMATION: The Health Resources and Services Administration’s (HRSA) Poison Control Program (PCP) was established in February 2000 under the Poison Center Enhancement and Awareness Act, Pub. L. 106–174. The program was reauthorized in 2003 under the Poison Control Center Enhancement and Awareness Act, Amendments of 2003, Pub. L. 108–194. This Act authorizes funding to maintain the national tollfree number; establish a nationwide media campaign to promote poison control center (PCC) utilization; maintain the PCC grant program; develop standardized poison prevention and poison control promotion programs; develop standard patient management guidelines for commonly encountered toxic exposures; improve and expand the poison control data collection activities; improve national toxic exposure surveillance by enhancing activities at the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease E:\FR\FM\13FEN1.SGM 13FEN1

Agencies

[Federal Register Volume 72, Number 29 (Tuesday, February 13, 2007)]
[Notices]
[Pages 6737-6738]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-2362]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Heritable Disorders and Genetic Diseases in 
Newborns and Children

AGENCY: Health Resources and Services Administration (HRSA), HHS.

ACTION: Notice of request for nominations.

-----------------------------------------------------------------------

SUMMARY: The Health Resources and Services Administration (HRSA) is 
requesting nominations to fill eight (8) vacancies on the Advisory 
Committee on Heritable Disorders and Genetic Diseases in Newborns and 
Children.

    Authority: Section 1111 of the PHS Act, 42 U.S.C. 300b-10. The 
Committee is governed by the provisions of Public Law 92-463, as 
amended (5 U.S.C. App. 2), and 41 CFR Part 102-3, which sets forth 
standards for the formation and use of advisory committees.

DATES: The agency must receive nominations on or before March 15, 2007.

ADDRESSES: All nominations are to be submitted to Michele A. Lloyd-
Puryear, M.D., Ph.D., Designated Federal Official and Executive 
Secretary, Advisory Committee on Heritable Disorders and Genetic 
Diseases in Newborns and Children, and Chief, Genetic Services Branch, 
Maternal and Child Health Bureau, Health Resources and Services 
Administration, Room 18A-19, Parklawn Building, 5600 Fishers Lane, 
Rockville, Maryland 20857. Nominations will not be accepted by e-mail 
or facsimilie.

FOR FURTHER INFORMATION CONTACT: Ms. Jill F. Shuger, Genetic Services 
Branch, Maternal and Child Health Bureau, HRSA, at jshuger@hrsa.gov or 
(301) 443-1080. A copy of the Committee Charter and list of the current 
membership can be obtained by contacting Ms. Shuger or by accessing the 
Advisory Committee Web site at http://mchb.hrsa.gov/programs/genetics/
committee.

SUPPLEMENTARY INFORMATION: Title XXVI of the Children's Health Act of 
2000, ``Screening for Heritable Disorders,'' established a program to 
improve the ability of States to provide newborn and child screening 
for heritable disorders. Title XXVI enacts three sections of the Public 
Health Service (PHS) Act: Sections 1109, 1110, and 1111. The Secretary 
of Health and Human Services (HHS) is directed under section 1111 of 
the PHS Act to establish an Advisory Committee on Heritable Disorders 
in Newborns and Children (Committee). HHS has expanded the Committee to 
include genetic diseases and has renamed the Committee accordingly.
    The Committee is established to advise and guide the Secretary 
regarding the most appropriate application of universal newborn 
screening tests, technologies, policies, guidelines and programs for 
effectively reducing morbidity and mortality in newborns and children 
having or at risk for heritable disorders. In addition, the Committee 
provides advice and recommendations to the Secretary concerning the 
grants and projects authorized under section 1109 and technical 
information to develop policies and priorities for this Program that 
will enhance the ability of the State and local health agencies to 
provide for newborn and child screening, counseling and health care 
services for newborns and children having or at risk for heritable 
disorders.
    Specifically, HRSA is requesting nominations for eight voting 
members to serve on the Committee. Members shall be selected from 
medical, technical, public health or scientific professionals with 
special expertise in the field of heritable disorders or in providing 
screening, counseling, testing or specialty services for newborns and 
children at risk for heritable disorders and from members of the public 
having

[[Page 6738]]

special expertise about or concern with heritable disorders.
    The individuals selected for appointment to the Committee can be 
invited to serve for overlapping terms of up to 4 years. However, any 
member appointed to fill a vacancy of an unexpired term shall be 
appointed for the remainder of such term. Members may serve after the 
expiration of their term until their successors have taken office. 
Terms of more than 2 years are contingent upon the renewal of the 
Committee by appropriate action prior to its expiration. Members who 
are not Federal employees will receive a stipend for each day they are 
engaged in the performance of their duties as members of the Committee. 
Members shall receive per diem and travel expenses as authorized by 
Section 5 U.S.C. 5703 for persons employed intermittently in Government 
service. Members who are officers or employees of the United States 
Government shall not receive compensation for service on the Committee. 
Nominees will be invited to serve beginning from September 30, 2007.
    To allow the Secretary to choose from a highly qualified list of 
potential candidates, more than one nomination is requested per open 
position. Nominations should be typewritten. The following information 
should be included in the package of material submitted for each 
individual being nominated for consideration: (1) A letter of 
nomination that clearly states the name and affiliation of the nominee, 
the basis for the nomination (i.e., specific attributes which qualify 
the nominee for service in this capacity), and a statement that the 
nominee is willing to serve as a member of the Committee and appears to 
have no conflict of interest that would preclude the Committee 
membership--potential candidates will be asked to provide detailed 
information concerning consultancies, research grants, or contracts to 
permit evaluation of possible sources of conflicts of interest; (2) the 
nominator's name, address, and daytime telephone number, and the home/
or work address, telephone number, and e-mail address of the individual 
being nominated; and (3) a current copy of the nominee's curriculum 
vitae. Please submit nominations no later than March 15, 2007.
    To the extent practicable, members of the Committee should have 
expertise in dealing with heritable disorders and genetic diseases that 
affect the racial and ethnic and geographical diversity of newborns 
served by the State newborn screening programs. The Department of 
Health and Human Services will ensure that the membership of the 
Committee reflects an equitable geographical and gender distribution, 
provided that the effectiveness of the Committee would not be impaired. 
Appointments shall be made without discrimination on the basis of age, 
ethnicity, gender, sexual orientation, and cultural, religious, or 
socioeconomic status.

    Dated: February 6, 2007.
Elizabeth M. Duke,
Administrator.
 [FR Doc. E7-2362 Filed 2-12-07; 8:45 am]
BILLING CODE 4165-15-P